Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
NSU Oklahoma College of Optometry opens new facility
Published on August 1, 2025
The new facility has opened just in time to see its first classes held in the fall semester.
Continue reading on website
Other news
LENZ Therapeutics Announces FDA Approval of VIZZ for Treatment of Presbyopia
August 1, 2025
SAN DIEGO—LENZ Therapeutics, Inc. (Nasdaq: LENZ) announced yesterday that the company has received U.S. Food and Drug Administration (FDA) approval for VIZZ (aceclidine ophthalmic solution) 1.44%. With this step, the solution becomes the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults. Samples are expected to be available in the United States as earl
New Eye Drop Approved for Presbyopia
August 1, 2025
Vizz, the first aceclidine-based solution for presbyopia, was shown in clinical trials to improve near vision in as little as 30 minutes, with effects lasting up to 10 hours. Photo: Lenz Therapeutics. Click image to enlarge. Nearly four years after the launch of Allergan’s pilocarpine-based Vuity comes the approval of Vizz (aceclidine ophthalmic solution 1.44%), the second e